Paul Clopton

Active 1989–2025

87
Papers
21,078
Citations
72
h-index
83
i10-index

Citations

Citations per year for Paul Clopton1990: 1 citations1991: 1 citations1992: 1 citations1993: 1 citations1995: 6 citations1996: 4 citations1997: 3 citations1998: 5 citations1999: 13 citations2000: 13 citations2001: 24 citations2002: 91 citations2003: 162 citations2004: 325 citations2005: 255 citations2006: 190 citations2007: 208 citations2008: 140 citations2009: 132 citations2010: 108 citations2011: 105 citations2012: 110 citations2013: 147 citations2014: 168 citations2015: 195 citations2016: 180 citations2017: 165 citations2018: 160 citations2019: 438 citations2020: 395 citations2021: 382 citations2022: 314 citations2023: 206 citations2024: 317 citations2025: 152 citations2026: 9 citations1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,677 citing papers, 26.1% of this breakdownUnited Kingdom: 427 citing papers, 6.6% of this breakdownGermany: 375 citing papers, 5.8% of this breakdownItaly: 368 citing papers, 5.7% of this breakdownChina: 336 citing papers, 5.2% of this breakdownNetherlands: 299 citing papers, 4.7% of this breakdownCanada: 247 citing papers, 3.8% of this breakdownFrance: 244 citing papers, 3.8% of this breakdownAustralia: 190 citing papers, 3% of this breakdownSpain: 183 citing papers, 2.8% of this breakdownSwitzerland: 177 citing papers, 2.8% of this breakdownJapan: 175 citing papers, 2.7% of this breakdown
0%26.1%Other 27%

Fields

  • Medicine81.3%
  • Biochemistry, Genetics and Molecular Biology5.7%
  • Neuroscience3.4%
  • Immunology and Microbiology3%
  • Psychology2.8%
  • Engineering1.2%
  • Other2.6%

Topics

  • Heart Failure Treatment and Management8.9%
  • Cardiovascular Function and Risk Factors5.5%
  • Atrial Fibrillation Management and Outcomes4.9%
  • Cardiac electrophysiology and arrhythmias3.7%
  • Cardiac Arrhythmias and Treatments3.6%
  • Liver Disease Diagnosis and Treatment3%
  • Other70.4%

Coauthors

All papers

Open in search
  1. Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , , - Gastroenterology 2013 cited by 915

  2. Treatment of Atrial Fibrillation by the Ablation of Localized Sources

    Authors: , , , , , - Journal of the American College of Cardiology 2012 cited by 1,105

  3. Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2002 cited by 3,352

  4. Machine Learning–Enabled Multimodal Fusion of Intra-Atrial and Body Surface Signals in Prediction of Atrial Fibrillation Ablation Outcomes

    Authors: , , , , , , , , , , , - Circulation Arrhythmia and Electrophysiology 2022 cited by 78

  5. LPA Gene, Ethnicity, and Cardiovascular Events

    Authors: , , , , , , - Circulation 2016 cited by 139

  6. Machine learning of electrophysiological signals for the prediction of ventricular arrhythmias: systematic review and examination of heterogeneity between studies

    Authors: , , , , , , , , - EBioMedicine 2023 cited by 50

  7. Dynamic prediction of malignant ventricular arrhythmias using neural networks in patients with an implantable cardioverter-defibrillator

    Authors: , , , , , , , , , , , , - EBioMedicine 2023 cited by 30

  8. Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults

    Authors: , , , , - Circulation 2011 cited by 238

  9. Atrial fibrillation ablation outcome prediction with a machine learning fusion framework incorporating cardiac computed tomography

    Authors: , , , , , , , , , , , , , - Journal of Cardiovascular Electrophysiology 2023 cited by 31

  10. Machine Learning to Classify Intracardiac Electrical Patterns During Atrial Fibrillation

    Authors: , , , , , , , , , , - Circulation Arrhythmia and Electrophysiology 2020 cited by 72

  11. Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit

    Authors: , , , , , , , , , , , , , , - EP Europace 2023 cited by 27

  12. B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2002 cited by 885

  13. Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2010 cited by 509

  14. Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors

    Authors: , , , , , , , - Circulation 2009 cited by 144

  15. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure

    Authors: , , , , , , , , , , , , , , , , , , , - American Heart Journal 2006 cited by 273

  16. Pro-Inflammatory Interleukin-1 Genotypes Potentiate the Risk of Coronary Artery Disease and Cardiovascular Events Mediated by Oxidized Phospholipids and Lipoprotein(a)

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2014 cited by 138

  17. Effect of Spironolactone on 30-Day Death and Heart Failure Rehospitalization (from the COACH Study)

    Authors: , , , , , , , , , - The American Journal of Cardiology 2014 cited by 89

  18. A Behavioral Task Predicts Conversion to Mild Cognitive Impairment and Alzheimer’s Disease

    Authors: , , , , - American Journal of Alzheimer s Disease & Other Dementias® 2012 cited by 94

  19. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2001 cited by 823

  20. Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated Copeptin

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Heart Failure 2011 cited by 176

  21. B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the breathing not properly multinational study

    Authors: , , , , , , , , , , , , , , , , , , - American Journal of Kidney Diseases 2003 cited by 534

  22. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT)

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2004 cited by 433

  23. Repolarization Alternans Reveals Vulnerability to Human Atrial Fibrillation

    Authors: , , , , - Circulation 2011 cited by 192

  24. Knockdown of the β1 integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis

    Authors: , , , , , , , , , - International Journal of Cancer 2011 cited by 109